Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The ANZIBDC strives to improve the lives of those living with inflammatory bowel disease and ultimately find a cure for IBD. Our research spans areas of prospective clinical trials for new therapies, cohort studies to understand clinical outcomes and the natural history of IBD, studies involving genetics and phenotyping as well as projects specifically designed to audit and improve on patient quality of care. We value translational research which can directly impact on the lives of our patients.
In order to maintain our consortium and continue to pursue our research we require ongoing funding and support.
We work to develop long term partnerships which deliver clear benefits to our partners while allowing us to continue to undertake the important research activities which support our mission and our patients.
The strength of the ANZIBDC is our well established structure, strong history of collaboration on projects across our 17 sites, the high quality of research teams at our sites and the scientific rigour which goes into the development of our projects, supported by our scientific committee.
Our structure, processes and team enable us to produce high quality outcomes from our work in a timely manner.
If you are interested in partnering with us, please email us at anzibdc@mater.uq.edu.au.
Copyright © 2024 ANZIBDC - All Rights Reserved.
Powered by GoDaddy Website Builder
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.